Skip to content

Funding

Fusion Energy News

Community-owned · Subscriber-funded · No ads

Sunday, September 13, 2026

Vol. III · August 2026

All dispatches

Funding · med impact

Proxima Fusion joins the club of well-funded nuclear contenders with €130M Series A

Proxima Fusion, a spinoff from the Max Planck Institute for Plasma Physics, has secured €130 million in a Series A funding round to advance its quasi-isodynamic stellarator designs for commercial fusion power.

By Fusion Energy News Desk·Wed, 19 Aug 2026 06:01:59 GMT·8/19/2026, 6:02:00 AM·Reporting·✓ Editor-verified
Share

Proxima Fusion has raised €130 million in a Series A financing round, positioning it as a significant new entrant in the private fusion energy sector. The company, a direct spinoff from Germany's Max Planck Institute for Plasma Physics, aims to commercialize fusion energy based on the quasi-isodynamic (QI) stellarator concept. This funding establishes Proxima as one of Europe's most well-capitalized private fusion ventures and will support the development of its initial engineering designs and integrated systems. The round marks a notable investment in the stellarator architecture, a magnetic confinement approach that has historically received less private funding compared to tokamaks. Source: Proxima Fusion via Yahoo Finance

The company's technical foundation is built upon decades of public research conducted at the Wendelstein 7-X (W7-X) experiment, the world's most advanced stellarator. Proxima's strategy is to leverage the validated physics of the W7-X design, which has demonstrated stable high-temperature plasma confinement without the need for a large, disruption-prone plasma current characteristic of tokamaks. By building on this established scientific basis, the company intends to bypass fundamental physics risks and focus directly on the engineering challenges of designing a commercially viable fusion power plant. This approach aims to accelerate the development timeline by utilizing a proven plasma confinement concept. Source: Proxima Fusion via Yahoo Finance

The company's technical foundation is built upon decades of public research conducted at the Wendelstein 7-X (W7-X) experiment, the world's most advanced stellarator.

Proxima's QI stellarator design seeks to optimize plasma stability and particle confinement, addressing historical challenges in stellarator performance. The complex, non-planar magnetic coils required for a stellarator are computationally intensive to design but offer the prospect of steady-state operation, a critical requirement for a power plant. The company plans to integrate high-temperature superconducting magnets to achieve the strong, persistent magnetic fields necessary for fusion conditions. This combination of a validated physics model from W7-X with advanced magnet technology forms the core of Proxima's technical roadmap toward building a first-of-a-kind fusion device. Source: Proxima Fusion via Yahoo Finance

The €130 million capital injection will be allocated to expanding the company's engineering and physics teams, securing access to high-performance computing resources for simulation and design, and initiating partnerships for hardware development. A primary near-term objective is to complete the integrated design of a next-generation QI stellarator. This funding round reflects growing investor confidence in the private fusion industry and the maturation of alternative confinement concepts beyond the tokamak. Proxima's progress will be a key indicator of the commercial viability of stellarator-based fusion energy. Source: Proxima Fusion via Yahoo Finance

Reporting grounded in coverage from the original publisher read the source .

Weekly newsletter

Fusion Energy Weekly

The week in fusion: breakthroughs, companies, and capital — in your inbox. Free, every Monday.

Primary sources

Editorial standards: Fusion Energy News dispatches are compiled from primary filings, peer-reviewed papers, and on-the-record statements. Corrections: corrections@fusionenergynews.com · public log

Letters to the editor(0)

Sign in to write a letter

No letters yet. Be the first to write one.